* ALL Fields Required *
We will keep your email and information completely private
A large number of prescription and over-the-counter drugs are marketed in the US without FDA review and approval because they pre-date current drug regulations. The FDA has started to crack down on these drugs, requesting that manufacturers complete the updated drug approval process. The path to submit a New Drug Approval (NDA) is complicated and tricky, but with clear planning and strategic partnering, there are several approaches to obtaining the necessary agency review and approval.
This whitepaper will:
Download the whitepaper now to learn more about 505(b)(2) applications!